Featuring perspectives from Ms Blanca Ledezma, Dr Stacey Stein, Ms Amanda K Wagner and Dr Mark Yarchoan, including the following topics:
- Introduction (0:00)
- Adjuvant Therapy for Early-Stage Hepatocellular Carcinoma (HCC) (9:40)
- Role of Immunotherapy in Intermediate-Stage HCC (17:02)
- First-Line Therapy for Advanced HCC (19:56)
- Immunotherapy in the Management of Advanced Biliary Tract Cancers (BTCs) (44:29)
- Biomarker Testing Recommendations and the Use of FGFR Inhibitors for Advanced Cholangiocarcinoma (58:02)
- Potential Role of HER2-Targeted Therapy for BTCs (1:17:16)
CME information and select publications